A study on the effect of plant extract-containing beverages on immune function [Trial No. g2021004 (KO24)]

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000044042
• Lead Sponsor: Kao Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-05-01
• Study Completion: 2021-07-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

(1) During the test period, Subjects who may develop seasonal allergic symptoms such as pollinosis and may use medicines, or who are receiving medication related to it (2) Those who may have allergic symptoms to the test food. (3) Those who have had strokes due to cardiovascular disease (heart failure, angina, stroke, subarachnoid hemorrhage, etc.) or who are being treated. (4) Those with a history or signs of cerebrovascular disease or cardiovascular disease. (5) Those who suffering from liver disease, renal disease, respiratory disease, endocrine disorder, metabolic disorder, organ disorder, ventilation, rheumatism, autoimmune disease, psychiatric disease, cancer, infectious disease, etc. (6) Those with a history of gastrointestinal resection (excluding cecal resection) (7) Alcoholic drinkers (alcohol equivalent 60g / day or more) (8) Those who collected 200 mL of blood (donated blood, etc.) within 1 month or 400 mL or more within 3 months of the start of this study. (9) Those who have felt sick at the time of blood collection, or those who have difficulty in collecting blood because the blood vessels in the arm are difficult to see. (10) Those who are not day shifts such as night shifts and rotation shifts (11) Those who cannot take all the test foods (12) Those who have a history of vaccination (including influenza) 4 weeks before the start of the study (13) Within the last 2 weeks, those who have had mild wind symptoms such as fever, cough, sore throat (symptoms lasting more than 4 days), high fever, dyspnea, strong malaise, dysgeusia, or olfactory dysfunction or who have these now. (14) Those who have traveled abroad within one month (15) Those who plan to participate in other clinical trials during the trial participation period (16) Those deemed inappropriate to participate in this study by the principle investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified